Eli Lilly and Company’s Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina’s Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug discovery, clinical development and […]
Effective of October 1st, 2026, Dr. Frank Lison will succeed TOPTICA founder Dr. Wilhelm Kaenders as CTO/Vorstand of the TOPTICA Photonics group. Graefelfing, Germany — Following the company’s long-term succession plan designed to ensure continuity in leadership and sustained technological excellence, Frank Lison will take over the main responsibilities of Wilhelm Kaenders. Wilhelm will remain […]
Proven leader to drive sharper execution and faster breakthroughs across research, diagnostics, and advanced therapeutics Integrated DNA Technologies (IDT), a global leader in genomics, and Aldevron, a global leader in the production of DNA, RNA and protein, today announced that Jennifer Meade has been appointed president of IDT and Aldevron. As head of Aldevron since 2023, […]
Washington D.C. – PerkinElmer, global leader in analytical & testing solutions for applied and food markets and in specialized life sciences services, is pleased to announce that Michael Stubblefield, Chief Executive Officer of PerkinElmer, has been elected to the Board of Directors of the US-China Business Council (USCBC). Michael joins USCBC’s board as part of its […]
Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the appointment of Bruce Eaton, PhD as Chairman of the Board, with immediate effect. The appointment aligns with the […]
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahead of its 2026 Annual General Meeting (AGM) scheduled for June 18, 2026, […]
BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company’s new Chief Financial Officer, effective June 22. Faessler brings extensive finance leadership experience and expertise in managing complex organizations in the life science tools industry, positioning him to play a […]
SAN JOSE, Calif. — Complete Genomics today announced the appointment of Edward T. McMullen Jr. to its Board of Directors, further strengthening the company’s leadership in global business strategy, international relations and U.S. government affairs. McMullen served as U.S. ambassador to Switzerland and Liechtenstein from 2017 to 2021 and has more than three decades of experience spanning […]
Cambridge, UK – Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced the appointment of Dr. Kaveh Kahen as President. Commenting on his appointment, Dr. Kahen said: “I’m honored to join Abcam as President. For over 25 years, Abcam has played a critical role in advancing life sciences research […]
MilliporeSigma appoints Clara Sattler de Sousa e Brito and Robert Machinek to strengthen leadership team. Clara Sattler de Sousa e Brito appointed Head of Discovery Solutions, bringing extensive international leadership experience across healthcare, medtech and the chemical industry Robert Machinek appointed Head of Strategy & Business Development, bringing deep expertise in life science strategy, M&A […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
